Many healthcare professionals are questioning the U.S. Preventive Services Task Force's recent draft guidance, in which it recommends against prostate-specific antigen-based screening for prostate cancer in healthy men, according to a Florida Times-Union report.
Although David Thiel, MD, from the Mayo Clinic, agrees prostate cancer is overtreated and overdiagnosed among older men, he also believes the prostate cancer screening test is a proven life-saver.
Another healthcare professional, Scott Eggener, MD, from the University of Chicago Medical Center, said the task force's draft guidance may be "overaggressive" and "irresponsible," according to the report. The draft guidance is subject to public comment before the task force published final recommendations on PSA screening.